PARP3 and neoplasm: Cells are able to tolerate HR inhibition equally well in the presence or absence of PARP3 (Fig. 2c), in keeping with the observations that AZD2461, a compound that inhibits PARP1 and PARP2 but not PARP3, effectively causes BRCA-mutated tumour regression50.